The collagen shield as a collagenase inhibitor and clinical indicator of collagenase activity on the ocular surface.
Collagen shields applied to the corneas of patients with bacterial keratitis degrade rapidly, often within a few hours. Once treatment brings the infection under control, subsequently applied collagen shields degrade more slowly. In vitro models were established to evaluate the significance of these observations. Twenty-four and 72-hour collagen shields were incubated with collagenase from Clostridium histolyticum. The in vitro rate of digestion of the shields was directly proportional to the concentration of collagenase, with the rate of digestion of the 24-hour shields being greater than that of the 72-hour shields. Therefore, the rate of collagen shield degradation may be a clinically useful index of collagenase activity on the ocular surface. Ultrastructural studies of collagen shields from patients with acute bacterial keratitis revealed irregular degradation of shield matrix with no evidence of adherence of microorganisms or inflammatory cells. Co-incubation of deepithelialized rabbit corneas and collagen shields resulted in inhibition of the digestion of the rabbit corneas when the weight:weight ratio of collagen shield:rabbit cornea was increased to greater than or equal to 2:1. Collagen shields may inhibit corneal collagen degradation in infectious ulceration and melting disorders by effectively competing for collagenase on the ocular surface.
Schiff
W M
WM
Department of Pathology, New York Eye and Ear Infirmary, N.Y. 10003.
Speaker
M G
MG
McCormick
S A
SA
D000818:Animals; D001684:Biological Dressings; D003094:Collagen / Q000494:pharmacology* / Q000627:therapeutic use / Q000648:ultrastructure; D003315:Cornea / Q000201:enzymology*; D003320:Corneal Ulcer / Q000382:microbiology / Q000628:therapy; D006801:Humans; D003012:Microbial Collagenase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D011817:Rabbits
D003094:Collagen; D003012:Microbial Collagenase